Singular Health Group Ltd (ASX:SHG)
Australia · Delayed Price · Currency is AUD 0.1950
+0.0150 (8.33%)
Sep 9, 2026, 4:10 PM AEST
Singular Health Group Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 1.9 | 0.56 | 0.93 | 0.44 | 0.42 |
Other Revenue | 0.44 | - | - | - | 0 |
| 2.34 | 0.56 | 0.93 | 0.44 | 0.42 | |
Revenue Growth | 320.34% | -40.30% | 111.17% | 5.79% | -8.79% |
Cost of Revenue | - | 0.64 | 0.42 | 0.59 | 0.6 |
Gross Profit | 2.34 | -0.09 | 0.52 | -0.15 | -0.18 |
Selling, General & Admin | 5.28 | 2.85 | 2.19 | 2.67 | 2.79 |
Research & Development | 1.19 | - | - | - | - |
Other Operating Expenses | 0.04 | 0.07 | 0.03 | 0.01 | 0.03 |
Operating Expenses | 8.67 | 6.31 | 3.61 | 4.22 | 5.74 |
Operating Income | -6.33 | -6.4 | -3.09 | -4.37 | -5.92 |
Interest Expense | -0.01 | -0.01 | -0.1 | -0.43 | -0.01 |
Interest & Investment Income | - | 0.14 | 0.31 | 0 | 0.01 |
Earnings From Equity Investments | - | - | - | -0.01 | -0.06 |
EBT Excluding Unusual Items | -6.34 | -6.26 | -2.87 | -4.81 | -5.99 |
Gain (Loss) on Sale of Investments | - | - | -0 | -0.16 | - |
Pretax Income | -6.34 | -6.26 | -2.88 | -4.97 | -5.99 |
Earnings From Continuing Operations | -6.34 | -6.26 | -2.88 | -4.97 | -5.99 |
Earnings From Discontinued Operations | - | -0.11 | -2.05 | -0.42 | - |
Net Income | -6.34 | -6.38 | -4.92 | -5.39 | -5.99 |
Net Income to Common | -6.34 | -6.38 | -4.92 | -5.39 | -5.99 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 312 | 237 | 160 | 110 | 103 |
Shares Outstanding (Diluted) | 312 | 237 | 160 | 110 | 103 |
Shares Change | 31.76% | 48.02% | 45.63% | 6.98% | 38.82% |
EPS (Basic) | -0.02 | -0.03 | -0.03 | -0.05 | -0.06 |
EPS (Diluted) | -0.02 | -0.03 | -0.03 | -0.05 | -0.06 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -5.45 | -2.37 | -2.51 | -2.43 | -2.92 |
Free Cash Flow Per Share | -0.02 | -0.01 | -0.02 | -0.02 | -0.03 |
Gross Margin | 100.00% | -15.46% | 55.28% | -32.87% | -43.02% |
Operating Margin | -270.09% | -1147.05% | -330.80% | -987.82% | -1415.80% |
Profit Margin | -270.51% | -1143.49% | -527.23% | -1218.59% | -1431.58% |
Free Cash Flow Margin | -232.36% | -425.12% | -269.13% | -548.25% | -697.75% |
EBITDA | -6.25 | -6.27 | -2.58 | -4.05 | -5.72 |
EBITDA Margin | -266.64% | - | -276.50% | - | - |
D&A For EBITDA | 0.08 | 0.13 | 0.51 | 0.32 | 0.2 |
EBIT | -6.33 | -6.4 | -3.09 | -4.37 | -5.92 |
EBIT Margin | -270.09% | - | - | - | - |